DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • May 2nd, 2006 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This License and Development Agreement is made as of February 1, 2006 (the “Effective Date”) by and between BioCryst Pharmaceuticals, Inc., a company organized and existing under the laws of Delaware having offices at 2190 Parkway Lake Drive, Birmingham, Alabama 35244 (“BioCryst”) and Mundipharma International Holdings Limited, a Bermudan company, having offices at Mundipharma House, 14 Par-la-Ville Road, Hamilton, Bermuda HMJX (“Mundipharma”) (hereinafter, each of BioCryst and Mundipharma a “Party” and, collectively, the “Parties”).
